Puma Biotechnology (PBYI) PT Lowered to $24 at Goldman Sachs
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $8.03 -2.31%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Puma Biotechnology (NASDAQ: PBYI) to $24.00 (from $29.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intercontinental Exchange (ICE) PT Lowered to $190 at UBS Following June Metrics Release
- AppLovin Corp (APP) PT Raised to $575 at Wells Fargo
- RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
